The University of Chicago Header Logo

Connection

Anita S. Chong to Rats

This is a "connection" page, showing publications Anita S. Chong has written about Rats.
Connection Strength

1.082
  1. A novel triptolide analog downregulates NF-?B and induces mitochondrial apoptosis pathways in human pancreatic cancer. Elife. 2023 Oct 25; 12.
    View in: PubMed
    Score: 0.149
  2. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol. 2008 Jan 01; 180(1):261-8.
    View in: PubMed
    Score: 0.050
  3. Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG1 in a rat-to-mouse model. Am J Transplant. 2008 Jan; 8(1):32-40.
    View in: PubMed
    Score: 0.049
  4. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant. 2006 Jan; 6(1):69-75.
    View in: PubMed
    Score: 0.043
  5. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol. 2004 Jun 15; 172(12):7235-8.
    View in: PubMed
    Score: 0.039
  6. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
    View in: PubMed
    Score: 0.035
  7. Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation. 2002 Nov 15; 74(9):1236-41.
    View in: PubMed
    Score: 0.035
  8. Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles. Am J Transplant. 2002 Jul; 2(6):526-34.
    View in: PubMed
    Score: 0.034
  9. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
    View in: PubMed
    Score: 0.034
  10. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
    View in: PubMed
    Score: 0.033
  11. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
    View in: PubMed
    Score: 0.031
  12. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation. 2000 Nov; 7(4):275-83.
    View in: PubMed
    Score: 0.030
  13. Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation. Transplant Proc. 2000 Aug; 32(5):844-5.
    View in: PubMed
    Score: 0.030
  14. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
    View in: PubMed
    Score: 0.030
  15. Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1, 3-galactosyl-transferase knock-out mice. Transplant Proc. 2000 Aug; 32(5):1005.
    View in: PubMed
    Score: 0.030
  16. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
    View in: PubMed
    Score: 0.029
  17. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
    View in: PubMed
    Score: 0.029
  18. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
    View in: PubMed
    Score: 0.028
  19. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
    View in: PubMed
    Score: 0.027
  20. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
    View in: PubMed
    Score: 0.026
  21. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation. 1997 Dec 27; 64(12):1650-7.
    View in: PubMed
    Score: 0.025
  22. Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation. 1997 Aug 15; 64(3):448-53.
    View in: PubMed
    Score: 0.024
  23. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation. 1996 Jul 15; 62(1):90-6.
    View in: PubMed
    Score: 0.022
  24. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Transplant Proc. 1996 Apr; 28(2):684.
    View in: PubMed
    Score: 0.022
  25. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation. 1994 Apr 27; 57(8):1223-31.
    View in: PubMed
    Score: 0.019
  26. Nonimmune lymphocyte-macrophage interaction. I. Quantification by an automated colorimetric assay. Cell Immunol. 1985 May; 92(2):265-76.
    View in: PubMed
    Score: 0.010
  27. Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation. 2005 Jan 15; 79(1):17-22.
    View in: PubMed
    Score: 0.010
  28. The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice. Transplantation. 2001 Dec 15; 72(11):1817-25.
    View in: PubMed
    Score: 0.008
  29. Combination of antilymphocyte globulin and leflunomide leads to superior grafts. Transplant Proc. 2001 Feb-Mar; 33(1-2):569.
    View in: PubMed
    Score: 0.008
  30. The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation. 1999 Oct 15; 68(7):958-63.
    View in: PubMed
    Score: 0.007
  31. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
    View in: PubMed
    Score: 0.007
  32. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998 Sep 27; 66(6):692-8.
    View in: PubMed
    Score: 0.007
  33. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998 Jul 27; 66(2):152-7.
    View in: PubMed
    Score: 0.006
  34. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Transplantation. 1998 Jul 15; 66(1):1-5.
    View in: PubMed
    Score: 0.006
  35. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
    View in: PubMed
    Score: 0.006
  36. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
    View in: PubMed
    Score: 0.006
  37. Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
    View in: PubMed
    Score: 0.006
  38. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
    View in: PubMed
    Score: 0.006
  39. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
    View in: PubMed
    Score: 0.006
  40. Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc. 1997 Jun; 29(4):2209-10.
    View in: PubMed
    Score: 0.006
  41. Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation. 1997 Mar 15; 63(5):711-6.
    View in: PubMed
    Score: 0.006
  42. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. Transplantation. 1997 Mar 15; 63(5):716-21.
    View in: PubMed
    Score: 0.006
  43. Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1296-7.
    View in: PubMed
    Score: 0.006
  44. Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation. 1996 Apr 15; 61(7):1122-5.
    View in: PubMed
    Score: 0.006
  45. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc. 1996 Apr; 28(2):691-2.
    View in: PubMed
    Score: 0.006
  46. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration. 1996 Mar; 5(1):1-11.
    View in: PubMed
    Score: 0.005
  47. Pharmacologically induced regression of chronic transplant rejection. Transplantation. 1995 Nov 27; 60(10):1065-72.
    View in: PubMed
    Score: 0.005
  48. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology. 1995 Oct; 22(4 Pt 1):1236-42.
    View in: PubMed
    Score: 0.005
  49. Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res. 1995 Mar; 58(3):337-43.
    View in: PubMed
    Score: 0.005
  50. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
    View in: PubMed
    Score: 0.005
  51. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
    View in: PubMed
    Score: 0.005
  52. Leflunomide immunosuppression in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1599-600.
    View in: PubMed
    Score: 0.005
  53. Allograft ultraviolet-B irradiation in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1624-5.
    View in: PubMed
    Score: 0.005
  54. Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc. 1993 Feb; 25(1 Pt 1):745-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.